Marietta, GANCT06912633Now EnrollingIRB Ready

Retinitis Pigmentosa Clinical Trial in Marietta, GA

Access cutting-edge retinitis pigmentosa treatment through this clinical trial at a research site in Marietta. Study-provided care at no cost to qualified participants.

Sponsored by jCyte, Inc

Quick Self-Assessment

See if you qualify for this Marietta location

Preparing your pre-screening questions...

Expert Care in Marietta

Access retinitis pigmentosa specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related retinitis pigmentosa treatment provided free

Apply for This Marietta Location

Check if you qualify for this retinitis pigmentosa clinical trial in Marietta, GA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Marietta

    Convenient for GA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Marietta site if eligible
  4. 4Begin participation

About This Retinitis Pigmentosa Study in Marietta

This study evaluates the safety of a single injection of jCell (famzeretcel) comprising 8.8 million (8.8M) retinal progenitor cells over a six-month study period in a cohort of adult subjects with RP. Additionally, changes in visual function will be evaluated at six months between the active treatment group (8.8M jCell) compared to sham-treated controls.

Sponsor: jCyte, Inc

Who Can Participate

Inclusion Criteria

Clinical diagnosis of RP supported by at least 2 of the following clinical findings: (1) Loss of peripheral vision on formal visual field testing, (2) Symptoms of night blindness or difficulty adjusting to dim light, or (3) Optical coherence tomography (OCT) outer retinal atrophy consistent with RP. 2. Electroretinography (ERG) results that support diagnosis of RP including nondetectable or severely reduced rod responses (defined as less than 30% of the lower limit of normative values for the ERG lab performing the test), with prolonged implicit time OU (i.e., ensure bilateral involvement) and greater rod than cone loss. 3. Subject age ≥ 18 years and ≤ 60 years at time of signing of consent. 4. Interocular BCVA disparity ≤ 15 letters. 5. Central subfield thickness (CST) ≥ 130 µm in the study eye. 6. BCVA no better than 55 letters and no worse than 1 letter using the Early Treatment Diabetic Retinopathy Study (ETDRS) testing protocol in the study eye. 7. Ability

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Marietta?

Yes, this clinical trial (NCT06912633) has an active research site in Marietta, GA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Retinitis Pigmentosa Treatment Options in Marietta, GA

If you're searching for retinitis pigmentosa treatment options in Marietta, GA, this clinical trial (NCT06912633) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Marietta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced retinitis pigmentosa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all retinitis pigmentosa clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Marietta, GA

See all essential tremor clinical trials recruiting in Marietta — not just this study.

Browse Essential Tremor Trials in Marietta →

Browse More Trials by Condition

Essential Tremor TrialsSleep Apnea TrialsRetinitis Pigmentosa TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Marietta?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Marietta, GA